Yeah, but what exactly is left in that pipeline? I love buying beaten down out-of-favor biotechs but there has to be something of promise left in the pipeline for me to pull the trigger. I'm not so sure that exists with BPAX.
BPAX has only $.28 a share net cash as of today and a $12m a qtr burn - its currently trading 1.6x net cash as per my spreadsheet with about 15 months cash left